Monitoring Waterloo Region Hotspots: University of Waterloo Campus
Networks
-
Datasets
-
Variables
-
The objective of this study is to understand the distribution of immunity to SARS-CoV-2 on a University Campus, between sexes, age groups (students, faculty staff) and ethnic groups.
- Start Year
- 2021
- End Year
- 2022
| Investigators | Contacts |
|---|---|
|
|
Design
- Study design
- Cohort
- Follow Up
- Participants are followed 3 times over a 10 month period.
Recruitment
- Recruitment Target
-
- Individuals
Number of Participants
- Number of Participants
- 1,000
- Number of Participants with Biological Samples
- 1,000
Access
Availability of data and biosamples
| Possible Access to Data | |
| Possible Access to Biosamples | |
| Other |
Timeline
C19-UWC population
The population is composed of students, faculty and staff on the University of Waterloo Campus in Canada who were seeking a molecular test for COVID-19.
Selection Criteria
- Newborns
- Twins
- Countries
-
- Canada
- Territory
- Waterloo
- Ethnic Origin
-
- Health Status
-
- Other Criteria
- Seeking a molecular test for COVID-19
Recruitment
- Sources of recruitment
-
- Specific population
- Specific Population
-
- Other specific population : Students, faculty and staff on the University of Waterloo Campus
- Supplementary Information
-
Symptomatic patients will be recruited through the molecular testing centre at Campus Health Services and asymptomatic participants will be recruited from the campus populations.
Number of Participants
- Number of Participants
- 1,000
- Number of Participants with Biological Samples
- 1,000
Data Collection Events
| # | Name | Description | Start | End |
|---|---|---|---|---|
| 0 |
C19-UWC - Baseline
|
Information about vaccination status and the specific vaccine which was administered if partcipants are vaccinated was collected. Demographics information was collected from the CITF core survey. ... | 2021-01 | 2021-06 |
| 1 |
C19-UWC - Follow-up 1
|
Information about vaccination status and the specific vaccine which was administered, if participants are vaccinated, was collected. A blood sample was collected for testing of IgM, IgG and IgA ... | 2021-06 | 2021-09 |
| 2 |
C19-UWC - Follow-up 2
|
Information about vaccination status and the specific vaccine which was administered, if partcipants are vaccinated, was collected. A blood sample was collected for testing of IgM, IgG and IgA ... | 2021-09 | 2021-12 |
| 3 |
C19-UWC - Follow-up 3
|
Information about vaccination status and the specific vaccine which was administered, if partcipants are vaccinated, was collected. A blood sample was collected for testing of IgM, IgG and IgA ... | 2022-01 | 2022-03 |
Classifications
- Socio-demographic and economic characteristics
- Lifestyle and behaviours
- Birth, pregnancy and reproductive health history
- Perception of health, quality of life, development and functional limitations
- Diseases
- Symptoms and signs
- Medication and supplements
- Non-pharmacological interventions
- Health and community care services utilization
- Death
- Physical measures and assessments
- Laboratory measures
- Cognition, personality and psychological measures and assessments
- Life events, life plans, beliefs and values
- Preschool, school and work life
- Social environment and relationships
- Physical environment
- Administrative information
Socio-demographic and economic characteristics
Age/birthdate
Sex/gender
Family and household structure
Education
Residence
Ethnicity, race and religion
Labour force and retirement
Lifestyle and behaviours
Tobacco
Transportation
Leisure activities
Diseases
Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Endocrine, nutritional and metabolic diseases (E00-E90)
Diseases of the nervous system (G00-G99)
Diseases of the circulatory system (I00-I99)
Diseases of the respiratory system (J00-J99)
Diseases of the digestive system (K00-K93)
Diseases of the genitourinary system (N00-N99)
Diseases without precise specification or falling into multiple categories
Symptoms and signs
Symptoms related to multiple categories
Medication and supplements
Medication and supplement intake
Non-pharmacological interventions
Laboratory diagnosis interventions
Other and unspecified non-pharmacological interventions
Health and community care services utilization
Visits to health professionals
Hospitalizations
Physical measures and assessments
Anthropometry
Laboratory measures
Hematology
Virology
Social environment and relationships
Social participation
Physical environment
Housing characteristics
Built environment/neighbourhood characteristics